{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Failure-to-Warn Claim Targeting Branded Drug Held Preempted: Litigation-Driven Expert Analysis Is Not “Newly Acquired Information” for Purposes of the “Changes Being Effected” Regulation",
"url": "https://www.lexblog.com/2022/09/19/failure-to-warn-claim-targeting-branded-drug-held-preempted-litigation-driven-expert-analysis-is-not-newly-acquired-information-for-purposes-of-the-changes-being-effe/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-XG7KV4WB",
"url": "https://www.lexblog.com/lib/XG7KV4WB/"
},
"datePublished": "2022-09-19T05:00:00-04:00",
"dateModified": "2022-12-01T10:07:38-05:00",
"author": {
"@type": "Person",
"name": "Andrew Tauber"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Drug & Device Law Blogging Team"
},
"organizationScope": "at-publication",
"isPartOf": "Drug & Device Law",
"about": "Other",
"sourceUrl": "https://www.druganddevicelawblog.com/?p=26718",
"sourceStability": "may-move"
}